Category: Venture Financing Report

Q2 2021 Quarterly VC Update: Frederik Groce on the State of Venture Capital Investing

In conjunction with our Q2 Venture Financing Report, I sat down with Frederik Groce of Storm Ventures and BLCK VC to get his take on the state of venture capital investing. Key insights On the pace of the market: “The use of technology has been paramount for companies, organizations and institutions to operate through an unparalleled […]

Q4 2020 Quarterly VC Update: Sean Barrett on the State of Venture Capital Investing

In conjunction with our Q4 Venture Financing Report, Lauren Creel sat down with Sean Barrett of HMI Capital to get his take on the state of venture capital investing. Key Insights On going back to basics this year: “HMI made its first investment in early 2009. … Everything was for sale, and the experience […]

Q3 2020 Quarterly VC Update: Logan Bartlett on Continued Strength During the Pandemic as Deal Sizes Surge

In conjunction with our Q3 Venture Financing Report, Sacha Ross sat down with Logan Bartlett of Redpoint Ventures to get his take on the state of venture capital investing. Key Insights On valuations moving forward: “While the amount of capital in the system is so high, it’s discerning in nature, and some of […]

Q2 2020 Quarterly VC Update: Michael Lints on Navigating Through the Storm

In conjunction with our Q2 Venture Financing Report, I sat down with Michael Lints of Golden Gate Ventures to get his take on the state of venture capital investing. Key Insights On executing deals in the pandemic: The venture capital market is very connected. Although, for instance, Vietnam has managed COVID really well, it’s still […]

Q1 + April 2020 Quarterly VC Update: Tip of the Iceberg?

With the onset of the COVID-19 crisis in March, we decided to include April data in our first 2020 report to better illustrate any early indicators of effects of the pandemic on the financing environment. Additionally, we have broken out specific statistics by month and industry (technology/life sciences/other) to offer […]